CLB Leading the Way to Affordable Therapeutics
Q & A with Dr. John Zhang, COO of CL Biologics Question: What is CLB’s organizational goal? At CL Biologics…
read moreLed by Daniel Brindle, former President of Novartis Group Greater China, we have built an international team with industry veterans from global CDMO leaders and pharma giants.
Q & A with Dr. John Zhang, COO of CL Biologics Question: What is CLB’s organizational goal? At CL Biologics…
read moreBiomanufacturing 4.0 is a technology that is revolutionizing the way pharmaceuticals are produced. This new technology utilizes oversized stainless steel…
read moreSeptember 22, 2022, Shenzhen – CL Biologics (CLB) announces today at the CLB Watson Center for Life Sciences and Technology…
read more